Product Images Atorvastatin Calcium

This appears to be a graph showing the cumulative incidence of something, possibly a medical condition or side effect of a medication. The graph includes two lines, one labeled "Atorvastatin" and the other labeled "Placebo." The x-axis displays years, and the y-axis displays percentages ranging from 0 to 40. The graph seems to suggest that the incidence of the condition is lower in patients taking Atorvastatin compared to those taking a placebo, with a statistically significant difference indicated by the HR value and p-value.*

This is a chart showing the cumulative hazard in percentages for a Placebo and Aorvastatin over a 4-year follow-up period. The Placebo group had 157 cumulative hazards while the Aorvastatin group had 107. There was a statistically significant difference in the hazard ratio between the two groups with an HR of 0.63 (0.48-0.83) and a p-value of 0.001. The chart also shows the time to the first primary endpoint through the 4-year follow-up period, from year 0 to year 5.*

This is a statistical report showing the percentage of subjects experiencing an event under different dosages of Atorvastatin. The efficacy of the drug is measured by the hazard ratio (HR) and the p-value, which was statistically significant (P=0.0002). The graph represents the time to the first major cardiovascular endpoint in years.*

Product No. 9517-0 is a container of 90 tablets of Atorvastatin Calcium 20mg. It should be stored at 6870 7 OEGAEES £ location.*